Latest news for Nanosonics (OTC:NNCSF) Stock

Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the US to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.

Nanosonics Ltd

Project $1M Q3 '24: The Goal Is In Sight

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited has reported a strong finish to a challenging fiscal year 2024, marked by a ...

Nanosonics Limited Eyes Growth Amid Healthcare Trends

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited's 2024 Annual General Meeting concluded with all resolutions being carried, ...

Nanosonics Limited Reports Strong AGM Results

Project $1M: End Of A Journey With Mission Accomplished

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited has announced the quotation of 93,596 new ordinary fully paid securities on ...

Nanosonics Limited Announces New Securities Quotation

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited has announced the issuance of 239,762 performance rights as part of its empl...

Nanosonics Limited Issuance of New Performance Rights

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited has announced a change in the director's interest concerning its equity secu...

Nanosonics Limited Updates Director's Equity Interest

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited has experienced a significant change in the interests of its substantial hol...

Nanosonics Limited Sees Shift in Substantial Holder Interests

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited has announced the issuance of 2,248,299 ordinary fully paid shares as part o...

Nanosonics Limited Issues Shares for Employee Incentive

Nanosonics Limited (AU:NAN) has released an update. Nanosonics Limited has experienced a decrease in voting power by Mitsubishi UFJ Financial Group...

Nanosonics Sees Stake Reduction by Mitsubishi UFJ

ADBE

ADYEY

ADYYF

AMZN

ARKG

ASML

ASMLF

CMXHF

CSLLY

DDOG

ENPH

FICO

GOOG

GOOGL

MELI

MSCI

MSFT

NNCSF

PMCUF

PMDIY

SHOP

SNOW

TEAM

VEEV

Nanosonics

News

Intraday Update

Markets

Movers

Trading Ideas

AACAF

AACAY

AAGIY

AAIGF

AAMMF

AAUKF

AAVMY

AAVVF

ABBRF

ABCP

ABILF

ABMC

ABNAF

ABSSF

ACDVF

ACGBY

ACHFF

ACKRF

ACNDF

ACNNF

ACOPF

ACRL

ACSAY

ACUIF

ADAD

ADDDF

ADDYY

ADMT

AEGOF

AERG

AETUF

AEXAY

AFLYY

AGCBF

AGESY

AGFAF

AGGFF

AHCHY

AHEXY

AHGIF

AHKSF

AHKSY

AHWSF

AIBGY

AIBRF

AIQUY

AIRRF

AISSF

AJMPF

AJXGF

AKAOQ

AKBTY

AKZOY

ALBY

ALEAF

ALFVY

ALIAF

ALIF

ALIZF

ALLVF

ALMTF

ALPMY

ALSMY

ALVOF

ALYI

AMADY

AMAZ

AMBBY

AMIGY

AMKAF

AMKBF

AMKBY

AMLZF

AMMX

AMRQQ

AMXEF

ANEWF

ANGPY

ANPDF

ANPDY

ANSLY

ANTH

ANXGF

ANZBY

ANZLY

AOIFF

AOMFF

AOTVF

APELY

APHD

APMCF

AQARF

ARAFF

ARESF

ARGKF

ARKAY

ARNGF

ARREF

ARRRF

Stocks That Hit 52-Week Highs On Tuesday

<div>
	&nbsp;</div>
<div>
	Nanosonics (OTC:<a class="ticker" href="/stock/NNCSF#OTC">NNCSF</a>) announced today that has entered into a new Capital Reseller</div>
<div>
	agreement with GE Healthcare (NYSE:<a class="ticker" href="/stock/GE#NYSE">GE</a>) which will come into effect at the end of the current GE</div>
<div>
	Healthcare Distribution agreement. The new three year agreement commences on 1 July</div>
<div>
	2019 and provides GE Healthcare Capital Reseller rights as part of Nanosonics&rsquo; global</div>
<div>
	Ultrasound OEM program. The new arrangements provide GE Healthcare&rsquo;s customers</div>
<div>
	ongoing access to the state of the art trophon through the GE Healthcare ultrasound sales</div>
<div>
	channel in North America. As a result of the new agreement Nanosonics will gain a material</div>
<div>
	increase in both sales and margin on consumables in North America as of and beyond July</div>
<div>
	2019.</div>
<div>
	As the risk of cross contamination with ultrasound procedures leads to more international</div>
<div>
	guidelines being implemented, Nanosonics and GE Healthcare have also introduced a</div>
<div>
	framework that will allow Nanosonics and GE Healthcare to continually assess and</div>
<div>
	implement international capital reseller opportunities as new markets develop.</div>
<div>
	&ldquo;The trophon technology is clearly well advanced in establishing itself as standard of care in</div>
<div>
	North America. This is a great testimony not only to the excellent value proposition of the</div>
<div>
	technology but also the excellent support GE Healthcare has provided as a leader in</div>
<div>
	ultrasound solutions over the last six years. We very much welcome the opportunity to</div>
<div>
	continue our relationship with GE beyond the existing agreement as we continue to further</div>
<div>
	establish trophon as standard of care not only in North America but across international</div>
<div>
	markets&rdquo; said Michael Kavanagh, Nanosonics Chief Executive Officer and President.</div>
 

Contracts

Nanosonics Enters New Capital Reseller Agreement with GE Healthcare

Comments

Nanosonics

News

Latest news for Nanosonics (OTC:NNCSF) Stock

Tuesday, March 24, 2020

Friday, August 25, 2017

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga